Brainsway Ltd Cash Flow Conversion Efficiency
Brainsway Ltd cash flow conversion efficiency. Based on the latest financial reports, Brainsway Ltd (BWAY) has a cash flow conversion efficiency ratio of 0.080x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($6.36 Million) by net assets ($79.19 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Brainsway Ltd (2012–2025)
Cash flow conversion efficiency of Brainsway Ltd from 2012 to 2025. This chart illustrates how Brainsway Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BWAY stock price and chart for real-time trading data and today's change.
Brainsway Ltd Cash Flow Conversion Ratio Explained
Brainsway Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Brainsway Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Brainsway Ltd ranked by their cash flow conversion efficiency. Also see Brainsway Ltd (BWAY) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Baolingbao Biology Co Ltd
SHE:002286
|
0.059x |
|
China National Complete Plant Import & Export Corp Ltd
SHE:000151
|
0.042x |
|
BGT Group Co. Ltd.
SHE:300774
|
N/A |
|
Hampidjan hf
IC:HAMP
|
0.016x |
|
Wuhu Fuchun Dye and Weave Co.Ltd.
SHG:605189
|
0.362x |
|
Jiangsu Changqing Agrochemical Co Ltd
SHE:002391
|
0.055x |
|
Factorial Energy Inc.
NASDAQ:FAC
|
-0.131x |
|
Citra Putra Realty Tbk PT
JK:CLAY
|
3.955x |
Annual Cash Flow Conversion Efficiency for Brainsway Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Brainsway Ltd from 2012 to 2025. Review free cash flow generation of Brainsway Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $73.22 Million | $18.16 Million | 0.248x | +50.10% |
| 2024-12-31 | $62.31 Million | $10.30 Million | 0.165x | +435.19% |
| 2023-12-31 | $41.58 Million | $1.28 Million | 0.031x | +114.36% |
| 2022-12-31 | $45.40 Million | $-9.76 Million | -0.215x | -1494.17% |
| 2021-12-31 | $57.33 Million | $884.00K | 0.015x | +121.08% |
| 2020-12-31 | $19.63 Million | $-1.44 Million | -0.073x | +75.55% |
| 2019-12-31 | $24.22 Million | $-7.24 Million | -0.299x | +44.89% |
| 2018-12-31 | $6.95 Million | $-3.77 Million | -0.543x | -99.13% |
| 2017-12-31 | $12.72 Million | $-3.47 Million | -0.273x | -16.72% |
| 2016-12-31 | $10.29 Million | $-2.40 Million | -0.233x | +33.85% |
| 2015-12-31 | $12.89 Million | $-4.55 Million | -0.353x | -44.97% |
| 2014-12-31 | $15.58 Million | $-3.79 Million | -0.244x | -50.97% |
| 2013-12-31 | $14.65 Million | $-2.36 Million | -0.161x | +77.22% |
| 2012-12-31 | $7.92 Million | $-5.60 Million | -0.708x | -- |
About Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, … Read more